Literature DB >> 16919077

Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.

F H Herrmann1, G Auerswald, A Ruiz-Saez, M Navarrete, H Pollmann, S Lopaciuk, A Batorova, K Wulff.   

Abstract

Inherited factor X deficiency (FXD) is a rare (1:1,000,000) recessive bleeding disorder. The clinical and laboratory phenotypes of FXD are poorly correlated and few regional studies on the genotype and the clinical manifestations of FXD are known. To understand the association between clinical manifestations and causative genotype, detailed evaluation of bleeding pattern in a high number of patients is needed. This international study analysed the phenotype and genotype of 102 subjects from Central Europe (Germany, Poland and Slovakia) and Latin America (Costa Rica and Venezuela) with causative mutations in the F10 gene, via sequencing. Twenty-eight homozygous, seven compound-heterozygous and 67 heterozygous FXD subjects were characterized. Twenty-nine different causative mutations, including 15 novel mutations, were analysed. Spontaneous bleeding symptoms in 42 symptomatic individuals (26 homozygous, seven compound heterozygous and nine heterozygous) comprised easy bruising (55%), haematoma (43%), epistaxis (36%), haemarthrosis (33%), intracranial haemorrhage (ICH; 21%), and gastrointestinal (GI) haemorrhage (12%). The manifestation of bleeding symptoms in 9 of 67 (13%) symptomatic heterozygous subjects is described. The bleeding patterns of the enrolled patients showed differences that are associated with the types of F10 mutation, and the corresponding genotypes. The homozygous patients were evaluated for genotype-phenotype correlation. The results suggested that ICH seems to be associated with the F10 mutation Gly380Arg, and possibly with the mutations IVS7-1G>A and Tyr163delAT. A tentative association of other mutations to severe symptoms such as haemarthrosis and GI haemorrhage is reported. The severity of FXD, the genotype-phenotype association, and the results of regional studies are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919077     DOI: 10.1111/j.1365-2516.2006.01303.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  17 in total

1.  Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.

Authors:  Zhilian Hu; Yang Liu; Michael C Huarng; Marzia Menegatti; Deepak Reyon; Megan S Rost; Zachary G Norris; Catherine E Richter; Alexandra N Stapleton; Neil C Chi; Flora Peyvandi; J Keith Joung; Jordan A Shavit
Journal:  Blood       Date:  2017-06-02       Impact factor: 22.113

2.  Factor X deficiency: a rare cause of puberty menorrhagia.

Authors:  Virender Singh; Tania Kakkar; Sanjeev K Digra; Manisha Kakkar
Journal:  Indian J Pediatr       Date:  2012-06-14       Impact factor: 1.967

3.  The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.

Authors:  Qiulan Ding; Yiping Shen; Likui Yang; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

4.  A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu.

Authors:  Kenji Shinohara; Mayumi Adachi; Kumiko Matsui; Kazuhiro Matsuda; Satomi Nagaya; Eriko Morishita
Journal:  Int J Hematol       Date:  2008-02-13       Impact factor: 2.490

5.  Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Res       Date:  2014-08-20       Impact factor: 3.944

Review 6.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

7.  A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiency.

Authors:  Yanming Wang; Junjie Ma; Xinguang Liu; Yan Wang; Hui Wang; Li Wang; Qiulan Ding; Xiaoxia Chu; Ming Hou
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  An analysis of 8 cases of factor X deficiency.

Authors:  Nilam M Shah; Ashwin P Patel
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

Review 9.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

10.  Plasma-derived factor X concentrate compassionate use for hereditary factor X deficiency: Long-term safety and efficacy in a retrospective data-collection study.

Authors:  James N Huang; Ri Liesner; Steven K Austin; Kaan Kavakli; Chioma Akanezi
Journal:  Res Pract Thromb Haemost       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.